Coagulation factor IX (recombinant), Fc fusion protein

Coagulation factor IX (recombinant), Fc fusion protein
Trade Name Alprolix
Orphan Indication Hemophilia B
USA Market Approval USA
USA Designation Date 2008-10-30 00:00:00
Sponsor Bioverativ Therapeutics, Inc.;225 2nd Avenue;Waltham, Massachusetts, 02451